标题
Preclinical Alzheimer disease—the challenges ahead
作者
关键词
-
出版物
Nature Reviews Neurology
Volume 9, Issue 1, Pages 54-58
出版商
Springer Nature
发表日期
2012-11-27
DOI
10.1038/nrneurol.2012.241
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Amyloid-β–Associated Clinical Decline Occurs Only in the Presence of Elevated P-tau
- (2012) Rahul S. Desikan et al. ARCHIVES OF NEUROLOGY
- Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
- (2012) D. S. Knopman et al. NEUROLOGY
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Countrywide strategic plans on Alzheimer’s disease: Developing the framework for the international battle against Alzheimer’s disease
- (2011) Kyra Rosow et al. Alzheimers & Dementia
- Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Amyloid-beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B data
- (2011) Andrei G. Vlassenko et al. ANNALS OF NEUROLOGY
- An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
- (2011) Clifford R. Jack et al. ANNALS OF NEUROLOGY
- Cerebrospinal Fluid Biomarkers, Education, Brain Volume, and Future Cognition
- (2011) Catherine M. Roe ARCHIVES OF NEUROLOGY
- Effect of APOE ε4 Status on Intrinsic Network Connectivity in Cognitively Normal Elderly Subjects
- (2011) Mary M. Machulda ARCHIVES OF NEUROLOGY
- Amyloid-Dependent and Amyloid-Independent Stages of Alzheimer Disease
- (2011) Bradley T. Hyman ARCHIVES OF NEUROLOGY
- CSF biomarkers for Alzheimer's disease: current utility and potential future use
- (2011) David M. Holtzman NEUROBIOLOGY OF AGING
- Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia
- (2011) William E. Klunk NEUROBIOLOGY OF AGING
- APOE modifies the association between A load and cognition in cognitively normal older adults
- (2011) K. Kantarci et al. NEUROLOGY
- Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease
- (2011) J. Karlawish NEUROLOGY
- Default mode network connectivity in stable vs progressive mild cognitive impairment
- (2011) J. R. Petrella et al. NEUROLOGY
- Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
- (2011) Todd E. Golde et al. NEURON
- Testing the Right Target and Right Drug at the Right Stage
- (2011) R. A. Sperling et al. Science Translational Medicine
- Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease
- (2010) Yakeel T. Quiroz et al. ANNALS OF NEUROLOGY
- Malignant Astrocytomas
- (2010) Hassan M. Fathallah-Shaykh ARCHIVES OF NEUROLOGY
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
- (2010) Christopher C. Rowe et al. NEUROBIOLOGY OF AGING
- Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline
- (2010) J. L. O'Brien et al. NEUROLOGY
- Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
- (2009) John C. Morris et al. ARCHIVES OF NEUROLOGY
- Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
- (2009) Susan M. Landau et al. NEUROBIOLOGY OF AGING
- Disclosure ofAPOEGenotype for Risk of Alzheimer's Disease
- (2009) Robert C. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started